Skip to main content

Rehmann Capital Advisory Group

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1633037 LANSING, MI

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,848,927
+$18,824 QoQ
Shares Held
2,393
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rehmann Capital Advisory Group holds $2,772,824 across 3 Biotechnology names. REGN ranks #1 (66.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
2,393 $1,848,927

All Filings in REGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,848,927 2,393
2025-12-31 $1,830,103 2,371
2025-09-30 $1,207,755 2,148
2025-06-30 $883,575 1,683
2025-03-31 $920,901 1,452
2024-12-31 $485,809 682
2024-09-30 $565,567 538
2024-06-30 $663,199 631
2024-03-31 $578,456 601
2023-12-31 $461,102 525
2023-09-30 $397,489 483
2023-06-30 $332,684 463
2023-03-31 $369,751 450
2022-12-31 $288,596 400
2022-09-30 $318,946 463
2022-06-30 $268,964 455
2022-03-31 $695,626 996
2021-12-31 $598,049 947
2021-09-30 $546,477 903
2021-06-30 $487,046 872
2021-03-31 $471,247 996
2020-12-31 $442,045 915